Literature DB >> 19549783

Mechanism for HIV-1 Tat insertion into the endosome membrane.

Hocine Yezid1, Karidia Konate, Solène Debaisieux, Anne Bonhoure, Bruno Beaumelle.   

Abstract

The human immunodeficiency virus, type 1, transactivating protein Tat is a small protein that is strictly required for viral transcription and multiplication within infected cells. The infected cells actively secrete Tat using an unconventional secretion pathway. Extracellular Tat can affect different cell types and induce severe cell dysfunctions ranging from cell activation to cell death. To elicit most cell responses, Tat needs to reach the cell cytosol. To this end, Tat is endocytosed, and low endosomal pH will then trigger Tat translocation to the cytosol. Although this translocation step is critical for Tat cytosolic delivery, how Tat could interact with the endosome membrane is unknown, and the key residues involved in this interaction require identification. We found that, upon acidification below pH 6.0 (i.e. within the endosomal pH range), Tat inserts into model membranes such as monolayers or lipid vesicles. This insertion process relies on Tat single Trp, Trp-11, which is not needed for transactivation and could be replaced by another aromatic residue for membrane insertion. Nevertheless, Trp-11 is strictly required for translocation. Tat conformational changes induced by low pH involve a sensor made of its first acidic residue (Glu/Asp-2) and the end of its basic domain (residues 55-57). Mutation of one of these elements results in membrane insertion above pH 6.5. Tat basic domain is also required for efficient Tat endocytosis and membrane insertion. Together with the strict conservation of Tat Trp among different virus isolates, our results point to an important role for Tat-membrane interaction in the multiplication of human immunodeficiency virus type 1.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19549783      PMCID: PMC2755682          DOI: 10.1074/jbc.M109.023705

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  51 in total

Review 1.  Cell-penetrating peptides.

Authors:  M Lindgren; M Hällbrink; A Prochiantz; U Langel
Journal:  Trends Pharmacol Sci       Date:  2000-03       Impact factor: 14.819

Review 2.  Penetration of protein toxins into cells.

Authors:  P O Falnes; K Sandvig
Journal:  Curr Opin Cell Biol       Date:  2000-08       Impact factor: 8.382

3.  Internalization of HIV-1 tat requires cell surface heparan sulfate proteoglycans.

Authors:  M Tyagi; M Rusnati; M Presta; M Giacca
Journal:  J Biol Chem       Date:  2000-10-06       Impact factor: 5.157

4.  Selective CXCR4 antagonism by Tat: implications for in vivo expansion of coreceptor use by HIV-1.

Authors:  H Xiao; C Neuveut; H L Tiffany; M Benkirane; E A Rich; P M Murphy; K T Jeang
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-10       Impact factor: 11.205

5.  1H-13C nuclear magnetic resonance assignment and structural characterization of HIV-1 Tat protein.

Authors:  J M Péloponèse; C Grégoire; S Opi; D Esquieu; J Sturgis; E Lebrun; E Meurs; Y Collette; D Olive; A M Aubertin; M Witvrow; C Pannecouque; E De Clercq; C Bailly; J Lebreton; E P Loret
Journal:  C R Acad Sci III       Date:  2000-10

6.  Molecular dynamics simulations on HIV-1 Tat.

Authors:  Sergio Pantano; Mudit Tyagi; Mauro Giacca; Paolo Carloni
Journal:  Eur Biophys J       Date:  2003-11-08       Impact factor: 1.733

7.  Molecular dynamics simulations suggest a mechanism for translocation of the HIV-1 TAT peptide across lipid membranes.

Authors:  Henry D Herce; Angel E Garcia
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-18       Impact factor: 11.205

8.  Uptake of HIV-1 tat protein mediated by low-density lipoprotein receptor-related protein disrupts the neuronal metabolic balance of the receptor ligands.

Authors:  Y Liu; M Jones; C M Hingtgen; G Bu; N Laribee; R E Tanzi; R D Moir; A Nath; J J He
Journal:  Nat Med       Date:  2000-12       Impact factor: 53.440

9.  A direct role for phosphatidylinositol-4,5-bisphosphate in unconventional secretion of fibroblast growth factor 2.

Authors:  Koen Temmerman; Antje D Ebert; Hans-Michael Müller; Irmgard Sinning; Ivo Tews; Walter Nickel
Journal:  Traffic       Date:  2008-04-16       Impact factor: 6.215

10.  HIV-1 Tat activates dual Nox pathways leading to independent activation of ERK and JNK MAP kinases.

Authors:  Ru Feng Wu; Zhenyi Ma; David P Myers; Lance S Terada
Journal:  J Biol Chem       Date:  2007-10-16       Impact factor: 5.157

View more
  19 in total

1.  Expression of human endogenous retrovirus type K (HML-2) is activated by the Tat protein of HIV-1.

Authors:  Marta J Gonzalez-Hernandez; Michael D Swanson; Rafael Contreras-Galindo; Sarah Cookinham; Steven R King; Richard J Noel; Mark H Kaplan; David M Markovitz
Journal:  J Virol       Date:  2012-05-16       Impact factor: 5.103

Review 2.  Defining the molecular mechanisms of HIV-1 Tat secretion: PtdIns(4,5)P2 at the epicenter.

Authors:  Anthony R Mele; Jamie Marino; Kenneth Chen; Vanessa Pirrone; Chris Janetopoulos; Brian Wigdahl; Zachary Klase; Michael R Nonnemacher
Journal:  Traffic       Date:  2018-04-30       Impact factor: 6.215

3.  Molecular mechanisms in the dramatic enhancement of HIV-1 Tat transduction by cationic liposomes.

Authors:  Guan-Han Li; Wenxue Li; Russell J Mumper; Avindra Nath
Journal:  FASEB J       Date:  2012-03-23       Impact factor: 5.191

Review 4.  Genetic variation and function of the HIV-1 Tat protein.

Authors:  Cassandra Spector; Anthony R Mele; Brian Wigdahl; Michael R Nonnemacher
Journal:  Med Microbiol Immunol       Date:  2019-03-05       Impact factor: 3.402

5.  HIV-1 Tat triggers nuclear localization of ZO-1 via Rho signaling and cAMP response element-binding protein activation.

Authors:  Yu Zhong; Bei Zhang; Sung Yong Eum; Michal Toborek
Journal:  J Neurosci       Date:  2012-01-04       Impact factor: 6.167

6.  Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting.

Authors:  Simon Beaudoin; Michel Paquette; Laurent Fafard-Couture; Mylene A Tremblay; Roger Lecomte; Brigitte Guérin; Jeffrey V Leyton
Journal:  J Vis Exp       Date:  2018-03-08       Impact factor: 1.355

7.  Design of aromatic-containing cell-penetrating peptide mimics with structurally modified π electronics.

Authors:  Brittany M deRonde; Alexander Birke; Gregory N Tew
Journal:  Chemistry       Date:  2014-12-23       Impact factor: 5.236

8.  Phosphatidylinositol-(4,5)-bisphosphate enables efficient secretion of HIV-1 Tat by infected T-cells.

Authors:  Fabienne Rayne; Solène Debaisieux; Hocine Yezid; Yea-Lih Lin; Clément Mettling; Karidia Konate; Nathalie Chazal; Stefan T Arold; Martine Pugnière; Françoise Sanchez; Anne Bonhoure; Laurence Briant; Erwann Loret; Christian Roy; Bruno Beaumelle
Journal:  EMBO J       Date:  2010-03-11       Impact factor: 11.598

9.  An unusual cell penetrating peptide identified using a plasmid display-based functional selection platform.

Authors:  Shan Gao; Melissa J Simon; Christopher D Hue; Barclay Morrison; Scott Banta
Journal:  ACS Chem Biol       Date:  2011-02-22       Impact factor: 5.100

10.  Skipped Over: Tuning Natural Killer Cells Toward HIV Through Alternative Splicing.

Authors:  Daniel R Ram; Kyle Kroll; R Keith Reeves
Journal:  AIDS Res Hum Retroviruses       Date:  2020-09-28       Impact factor: 2.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.